Vol 2, No 3 (2011)
Review paper
Published online: 2011-10-18

open access

Page views 1247
Article views/downloads 10361
Get Citation

Connect on Social Media

Connect on Social Media

Bendamustine in therapy of lymphoid malignancies

Iwona Hus, Anna Korycka-Wołowiec, Justyna Dzietczenia, Piotr Boguradzki, Tomasz Wróbel
Hematologia 2011;2(3):220-232.

Abstract

Bendamustine is cytotoxic agent combining structural and functional features of alkylating agents and purine analogues. Many clinical trials confirmed efficacy of bendamustine in therapy of lymphoid malignancies. This article summarizes results, clinical data and safety of treatment with bendamustine in patients with non-Hodgkin lymphomas, chronic lymphocytic leukemia and plasma cell myeloma.
Hematologia 2011; 2, 3: 220–232

Article available in PDF format

View PDF (Polish) Download PDF file



Hematology in Clinical Practice